Abiomed, Inc. (ABMD) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 14 PAGES: 44

More Info
									         Abiomed, Inc. (ABMD) - Financial and Strategic SWOT Analysis Review
        Reference Code: GDME841FSA                                                                                             Publication Date: JUN 2013

          22 Cherry Hill Drive                               Phone              +1 978 6461400                  Revenue          126.4 (million USD)
          Danvers, MA                                        Fax                +1 978 7778411                  Net Profit       15.01 (million USD)
          01923                                              Website            www.abiomed.com                 Employees        467
          United States                                      Exchange           ABMD [NASDAQ]                   Industry         Medical Equipment

       Company Overview
       Abiomed, Inc. (Abiomed) is a leading provider of mechanical circulatory support devices. The company undertakes the
       development, manufacture and marketing of novel technologies to replace or assist the life-sustaining pumping function of the
       failing heart. Its portfolio of products and services provide healthcare professionals a range of choices across a wide clinical
       spectrum.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Abiomed, Inc., SWOT Analysis
         Michael R. Minogue                  Chairman                                 Strengths                              Weaknesses
         W. Gerald Austen, M.D.              Director
                                                                                      Expertise in Circulatory Support Principal Manufacturing Facility
         Louis E. Lataif                     Director
                                                                                      Focused Research and                   Reliance on Distributors
         Dorothy E. Puhy                     Director
                                                                                      Development Activities
         Henri A. Termeer                    Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     Expansion in Customer Base             Cost Containment Pressures
         Abiomed, Inc.
                                                                                      Regulatory Approvals                   Dependence on Key Suppliers
        Share Price (USD) as on 21-Jun-                                21.25
        2013
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        EPS (USD)                                                        0.37        GlobalData
        Market Cap (million USD)                                         834
        Enterprise Value (million USD)                                   825
        Shares Outstanding (million)                                       39
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      May 28, 2013         Abiomed Gets Reimbursement Approval For
                                                                                                           Impella In Netherlands
                                                                                      May 02, 2013         Abiomed Reports Revenue Of $158.1m In
                                                                                                           Fiscal 2013
                                                                                      May 01, 2013         Abiomed Announces Publication Of Protect II
                                                                                                           Study Results Of Impella In AHDB Journal
                                                                                      Mar 07, 2013         Abiomed To Showcase Impella Technology At
                                                                                                           ACC 2013
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Abiomed, Inc. (ABMD) - Financial and Strategic SWOT Analysis                                                                     Reference Code: GDME841FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Abiomed, Inc. - Key Facts .................................................................................................................................................................. 5
       Abiomed, Inc. - Key Employees ......................................................................................................................................................... 6
       Abiomed, Inc. - Key Employee Biographies ....................................................................................................................................... 7
       Abiomed, Inc. - Major Products and Services..................................................................................................................................... 8
       Abiomed, Inc. - Medical Equipment Pipeline Products Data............................................................................................................... 9
          Abiomed, Inc. Pipeline Products by Equipment Type ..................................................................................................................... 9
          Abiomed, Inc. Pipeline Products by Development Stage .............................................................................................................. 11
       Abiomed, Inc. - History ..................................................................................................................................................................... 13
       Abiomed, Inc. - Company Statement................................................................................................................................................ 16
       Abiomed, Inc. - Locations And Subsidiaries ..................................................................................................................................... 17
          Head Office ................................................................................................................................................................................... 17
          Other Locations & Subsidiaries ..................................................................................................................................................... 17
       Abiomed, Inc. - Key Manufacturing Facilities.................................................................................................................................... 18
       Section 2 – Company Analysis ......................................................................................................................................................... 19
       Abiomed, Inc. - Business Description ............................................................................................................................................... 19
          Business Description - Research, Development and Sale of Medical Devices ............................................................................. 19
             Research, Development and Sale of Medical Devices - Overview ............................................................................................ 19
             Research, Development and Sale of Medical Devices - Financials .......................................................................................... 19
             Research, Development and Sale of Medical Devices - Market View ....................................................................................... 19
             Research, Development and Sale of Medical Devices - Technology ........................................................................................ 19
       Abiomed, Inc. - Corporate Strategy .................................................................................................................................................. 21
       Abiomed, Inc. - SWOT Analysis ....................................................................................................................................................... 22
          SWOT Analysis - Overview........................................................................................................................................................... 22
          Abiomed, Inc. - Strengths ............................................................................................................................................................. 22
             Strength - Expertise in Circulatory Support ............................................................................................................................... 22
             Strength - Focused Research and Development Activities ....................................................................................................... 22
             Strength - Constant Growth in Revenues .................................................................................................................................. 22
          Abiomed, Inc. - Weaknesses ........................................................................................................................................................ 22
             Weakness - Principal Manufacturing Facility ............................................................................................................................. 22
             Weakness - Reliance on Distributors ........................................................................................................................................ 23
             Weakness - Legal Proceedings ................................................................................................................................................. 23
          Abiomed, Inc. - Opportunities ....................................................................................................................................................... 23
             Opportunity - Expansion in Customer Base .............................................................................................................................. 23
             Opportunity - Regulatory Approvals .......................................................................................................................................... 23
             Opportunity - Growing Aged Population .................................................................................................................................... 24
          Abiomed, Inc. - Threats................................................................................................................................................................. 24
             Threat - Cost Containment Pressures ....................................................................................................................................... 24
             Threat - Dependence on Key Suppliers .................................................................................................................................... 24
             Threat - Competitive Atmosphere.............................................................................................................................................. 24
             Threat - Rapid Technological Changes ..................................................................................................................................... 24
       Abiomed, Inc. - Key Competitors ...................................................................................................................................................... 25


Abiomed, Inc. (ABMD) - Financial and Strategic SWOT Analysis                                                                                                      Reference Code: GDME841FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Section 3 – Company Financial Ratios ............................................................................................................................................. 26
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 26
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 26
       Performance Chart .............................................................................................................
								
To top